News & Events

Ultra-high-sensitivity Immunoassay for Assaying Amyloid and Tau Protein in Human Plasma for Diagnosing Alzheimer’s disease

July 21, 2016

Shieh-Yueh Yang, Ph.D., CEO MagQu Co., Ltd. In clinics, Alzheimer’s disease is identified by neuropsychological tests and neuroimaging. Such diagnosis takes time or costs. An immunoassay for detecting plasma biomarkers is greatly demanded. However, the known biomarkers in blood are rare. The assay methods to detect these plasma biomarkers must be very sensitive. In Yang's work, the ultra-high-sensitivity immunomagnetic reduction using magnetic nanoparticles are utilized to assay these...

Arizona State University and Banner Health launch major effort to fight neurodegenerative diseases

June 10, 2015

Tempe, Arizona – Arizona State University and Banner Health today announced a new research alliance to advance the scientific study, treatment and prevention of Alzheimer’s, Parkinson’s and other neurodegenerative diseases. The partnership between Arizona State University (ASU), one of the nation’s largest public research universities, and Phoenix-based Banner Health, one of the nation’s largest nonprofit health systems, includes the launch of a new Arizona State...